Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Carisma Therapeutics Inc.

    NASDAQ: CARM · Real-Time Price · USD
    0.45
    -0.05 (-10.41%)
    At close: Jun 20, 2025, 3:59 PM

    Carisma Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 19.63M 14.92M 9.83M 26.54M
    Cost of Revenue
    		 3.35M 74.13M 6.09M 85K
    Gross Profit
    		 16.28M -59.21M 3.74M 26.46M
    Operating Income
    		 -62.18M -88.73M -56.16M -40.79M
    Interest Income
    		 1.7M 1.94M 1.85M 10K
    Pretax Income
    		 -60.48M -86.88M -61.23M -40.78M
    Net Income
    		 -60.48M -86.88M -61.23M -40.78M
    Selling & General & Admin
    		 22.14M 29.52M 3.29M 6.41M
    Research & Development
    		 59.67M 74.13M 56.62M 34.39M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 81.81M 29.52M 59.91M 40.79M
    Interest Expense
    		 n/a n/a 3.15M n/a
    Selling & Marketing Expenses
    		 n/a n/a 30.41M n/a
    Cost & Expenses
    		 81.81M 103.65M 66M 40.79M
    Income Tax Expense
    		 n/a n/a -3.88M -10K
    Shares Outstanding (Basic)
    		 41.46M 33.52M 2.13M 9.12M
    Shares Outstanding (Diluted)
    		 41.46M 33.52M 2.13M 9.12M
    EPS (Basic)
    		 -1.46 -2.59 -575.42 -1.01
    EPS (Diluted)
    		 -1.46 -2.59 -575.42 -1.01
    EBITDA
    		 -58.83M -85.89M -51.99M -40.11M
    EBIT
    		 -60.48M -88.73M -58.08M -40.79M
    Depreciation & Amortization
    		 3.35M 2.84M 6.09M 85K

    Add to Watchlist